Properties (70)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Sun_Pharmaceutical_Industries
|
| gptkbp:advertising |
Mr._R._K._Sharma
Mr._R._S._Sharma Mr._S._P._Mehta Ms._P._K._Jain |
| gptkbp:employees |
over 10,000
|
| gptkbp:founded |
1961
|
| gptkbp:founder |
gptkb:B._D._Sanghvi
|
| gptkbp:hasOccupation |
Mr._R._S._Chawla
|
| gptkbp:hasResearchFocus |
gptkb:Dr._A._K._Sharma
|
| gptkbp:headCoach |
gptkb:Dr._R._K._Mehta
gptkb:Mr._R._K._Singh gptkb:Mr._A._K._Jain gptkb:Mr._A._K._Singh gptkb:Dr._R._S._Kharbanda Mr. S. K. Gupta Mr. S. P. Gupta Mr._A._K._Sinha Mr._A._P._Gupta Mr._A._S._Bansal Mr._A._S._Gupta Mr._P._K._Gupta Mr._P._K._Jain Mr._P._K._Mehta Mr._R._K._Agarwal Mr._R._K._Bansal Mr._R._S._Bansal Mr._R._S._Gupta Mr._R._S._Jain Mr._S._K._Mehta Mr._S._P._Singh Mr._V._K._Bansal Mr._V._K._Gupta Mr._V._K._Sethi Ms._N._K._Sharma Ms._N._S._Bansal Ms._N._S._Mehta Ms._P._R._Mehta |
| gptkbp:headOfMarketing |
gptkb:Mr._A._S._Chawla
gptkb:Mr._S._K._Jain Mr._A._K._Gupta Mr._A._K._Sharma |
| gptkbp:headquarters |
gptkb:Gurgaon,_India
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ranbaxy Laboratories
|
| gptkbp:market |
global
|
| gptkbp:partnerships |
various global pharmaceutical companies
Mr._V._K._Sharma |
| gptkbp:products |
antibiotics
generic drugs cardiovascular drugs diabetes medications dermatological products respiratory products gastrointestinal drugs pain management drugs oncology products anti-retroviral drugs CNS_products |
| gptkbp:regulatoryCompliance |
WHO approved
FDA_approved EMA_approved |
| gptkbp:researchAndDevelopment |
focus on complex generics
focus on active pharmaceutical ingredients focus on generics focus on new drug delivery systems |
| gptkbp:revenue |
$1.5 billion (2013)
|
| gptkbp:subsidiary |
gptkb:Ranbaxy_USA_Inc.
gptkb:Ranbaxy_Pharmaceuticals_Inc. Ranbaxy (UK) Ltd. |